Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Martin Schuler

Showing results (181-190 of 297) with videos related to

Pageof 30
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 14, 2010
ERBB2 induces an antiapoptotic expression pattern of Bcl-2 family members in node-negative breast cancerIlka Brigitte Petry, Esther Fieber, Marcus Schmidt, et al.
Oncology Research and Treatment|June 20, 2017
Comprehensive Biomarker Analyses in Patients with Advanced or Metastatic Non-Small Cell Lung Cancer Prospectively Treated with the Polo-Like Kinase 1 Inhibitor BI2536Frank Breitenbuecher, Joachim von Pawel, Martin Sebastian, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|June 25, 2026
SSTR-Targeted Radiotheranostics in Breast Cancer: A Comparison of [<sup>68</sup>Ga]Ga-DOTATOC and [<sup>68</sup>Ga]Ga-SSO120 with [<sup>18</sup>F]FDG PETAlina T Küper, Lalith Kumar Shiyam Sundar, Loíc Djaileb, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|July 20, 2023
<sup>68</sup>Ga-SSO-120 PET for Initial Staging of Small Cell Lung Cancer Patients: A Single-Center Retrospective StudyDavid Kersting, Patrick Sandach, Miriam Sraieb, et al.
Journal of Cancer Research and Clinical Oncology|May 17, 2023
Favorable survival outcomes in epidermal growth factor receptor (EGFR)-mutant non-small cell lung cancer sequentially treated with a tyrosine kinase inhibitor and osimertinib in a real-world settingOliver Kraskowski, Jan A Stratmann, Marcel Wiesweg, et al.
Oncogenesis|November 20, 2020
Functional screening identifies aryl hydrocarbon receptor as suppressor of lung cancer metastasisSilke Nothdurft, Clotilde Thumser-Henner, Frank Breitenbücher, et al.
British Journal of Cancer|December 23, 2016
EGFR mutation detection in circulating cell-free DNA of lung adenocarcinoma patients: analysis of LUX-Lung 3 and 6Yi-Long Wu, Lecia V Sequist, Cheng-Ping Hu, et al.
Cancer Immunology, Immunotherapy : CII|November 29, 2023
HPV-associated head and neck cancer is characterized by distinct profiles of CD8<sup>+</sup> T cells and myeloid-derived suppressor cellsBenjamin A Kansy, Tim P Wehrs, Kirsten Bruderek, et al.
Scientific Reports|April 3, 2020
Tumour cell PD-L1 expression is prognostic in patients with malignant pleural effusion: the impact of C-reactive protein and immune-checkpoint inhibitionBahil Ghanim, Anna Rosenmayr, Paul Stockhammer, et al.
Oncogene|December 21, 2018
Impact of RAS mutation subtype on clinical outcome-a cross-entity comparison of patients with advanced non-small cell lung cancer and colorectal cancerMarcel Wiesweg, Stefan Kasper, Karl Worm, et al.
Pageof 30

Showing results (181-190 of 297) with videos related to

Sort By:
Pageof 30
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 14, 2010
ERBB2 induces an antiapoptotic expression pattern of Bcl-2 family members in node-negative breast cancerIlka Brigitte Petry, Esther Fieber, Marcus Schmidt, et al.
Oncology Research and Treatment|June 20, 2017
Comprehensive Biomarker Analyses in Patients with Advanced or Metastatic Non-Small Cell Lung Cancer Prospectively Treated with the Polo-Like Kinase 1 Inhibitor BI2536Frank Breitenbuecher, Joachim von Pawel, Martin Sebastian, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|June 25, 2026
SSTR-Targeted Radiotheranostics in Breast Cancer: A Comparison of [<sup>68</sup>Ga]Ga-DOTATOC and [<sup>68</sup>Ga]Ga-SSO120 with [<sup>18</sup>F]FDG PETAlina T Küper, Lalith Kumar Shiyam Sundar, Loíc Djaileb, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|July 20, 2023
<sup>68</sup>Ga-SSO-120 PET for Initial Staging of Small Cell Lung Cancer Patients: A Single-Center Retrospective StudyDavid Kersting, Patrick Sandach, Miriam Sraieb, et al.
Journal of Cancer Research and Clinical Oncology|May 17, 2023
Favorable survival outcomes in epidermal growth factor receptor (EGFR)-mutant non-small cell lung cancer sequentially treated with a tyrosine kinase inhibitor and osimertinib in a real-world settingOliver Kraskowski, Jan A Stratmann, Marcel Wiesweg, et al.
Oncogenesis|November 20, 2020
Functional screening identifies aryl hydrocarbon receptor as suppressor of lung cancer metastasisSilke Nothdurft, Clotilde Thumser-Henner, Frank Breitenbücher, et al.
British Journal of Cancer|December 23, 2016
EGFR mutation detection in circulating cell-free DNA of lung adenocarcinoma patients: analysis of LUX-Lung 3 and 6Yi-Long Wu, Lecia V Sequist, Cheng-Ping Hu, et al.
Cancer Immunology, Immunotherapy : CII|November 29, 2023
HPV-associated head and neck cancer is characterized by distinct profiles of CD8<sup>+</sup> T cells and myeloid-derived suppressor cellsBenjamin A Kansy, Tim P Wehrs, Kirsten Bruderek, et al.
Scientific Reports|April 3, 2020
Tumour cell PD-L1 expression is prognostic in patients with malignant pleural effusion: the impact of C-reactive protein and immune-checkpoint inhibitionBahil Ghanim, Anna Rosenmayr, Paul Stockhammer, et al.
Oncogene|December 21, 2018
Impact of RAS mutation subtype on clinical outcome-a cross-entity comparison of patients with advanced non-small cell lung cancer and colorectal cancerMarcel Wiesweg, Stefan Kasper, Karl Worm, et al.
Pageof 30